(Q33859937)

29 July 2017

1 reference

title

Oral etoposide in germ cell tumours (English)

1 reference

29 July 2017

1 reference

Saxman S

1

1 reference

29 July 2017

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

58 Suppl 3

1 reference

29 July 2017

31-34

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958003-00005

29 July 2017

0 references

cites work

Treatment of testicular cancer: a new and improved model

1 reference

12 December 2020

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

1 reference

12 December 2020

A phase II study of oral VP-16-213 in non-seminomatous testicular cancer

1 reference

12 December 2020

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

1 reference

12 December 2020

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

12 December 2020

Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors

1 reference

12 December 2020

Phase II study of daily oral etoposide in refractory germ cell tumors

1 reference

12 December 2020

Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas

1 reference

12 December 2020

Surgical salvage of chemorefractory germ cell tumors

1 reference

12 December 2020

10.2165/00003495-199958003-00005

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10711839